Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug labels
Pharma
Amarin, after stock crash and layoffs, revives patent lawsuit
Amarin is getting a fresh shot to challenge Hikma Pharmaceuticals’ generic version of its fish-oil-derived heart med in the lower courts.
Fraiser Kansteiner
Jun 26, 2024 1:01pm
GSK's Arexvy has expanded its label into adults ages 50-59
Jun 7, 2024 6:45pm
Analysts tip label expansion to bolster GSK's hand in RSV fight
Feb 7, 2024 7:20am
Drug mix-up prompts Azurity to recall 1 lot of Zenzedi
Jan 26, 2024 9:41am
Teva hits wall in attempt to overturn 'skinny label' loss to GSK
May 15, 2023 11:15am
GSK throws latest punch in 'skinny label' fight with Teva
Apr 13, 2023 10:46am
